Related Experiment Video
Updated: Aug 6, 2026

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
Pediatric influenza prevention and control
Nicola Principi1, Susanna Esposito
1Institute of Pediatrics, University of Milan, Milan, Italy. nicola.principi@unimi.it
Insights
Global influenza vaccination rates in children are low, with high-risk children often unvaccinated. Increased efforts are crucial to protect vulnerable pediatric populations and encourage broader vaccination.
Area of Science:
- Pediatrics
- Vaccinology
- Public Health
Background:
- Current influenza vaccination recommendations for children are not consistently followed globally.
- A significant gap exists in vaccinating high-risk pediatric populations against influenza.
- Influenza poses substantial risks, including complications, particularly for young children.
Purpose of the Study:
- To evaluate global adherence to pediatric influenza vaccination guidelines.
- To identify key populations for enhanced influenza vaccination efforts.
- To highlight areas for improvement in pediatric influenza immunization strategies.
Main Methods:
- Global assessment of current influenza vaccination practices in children.
- Analysis of vaccination coverage among high-risk pediatric groups.
- Review of recommendations for healthy infants and children with specific conditions.
Main Results:
- Most children at high risk for influenza complications are not receiving the vaccine.
- Vaccination of healthy infants (6-23 months) and their contacts is underutilized.
- Vaccination is recommended for children with recurrent otitis media or respiratory infections, and potentially for healthy daycare/school-aged children.
Conclusions:
- Urgent need for increased efforts to improve pediatric influenza vaccination rates, especially for high-risk groups.
- Strong encouragement for vaccinating healthy infants and their close contacts is warranted.
- Addressing physician and parent education, vaccine cost-effectiveness, safety, supply, and intranasal product availability is essential for optimizing influenza prevention in children.
Abstract:
Global evaluation of influenza vaccination in children indicates that current recommendations are not followed. Most children at high risk for influenza-related complications do not receive the vaccine, and increased efforts are needed to protect them. Furthermore, vaccinating healthy infants 6-23 months of age and their close contacts should be strongly encouraged. Vaccinations are recommended for children with recurrent acute otitis media or recurrent respiratory tract infections and possibly for healthy daycare and school-age children because of the potential socioeconomic implications of influenza. Issues that need to be addressed include educating physicians and parents concerning influenza-related illness and complications, cost-effectiveness and safety of licensed vaccines, adequate vaccine supply, and availability of intranasal products.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Smallpox
Poliomyelitis
Influenza
Respiratory Syncytial Virus Disease

